Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Capital Leases (2021 - 2025)

Nutex Health's Capital Leases history spans 5 years, with the latest figure at $268.9 million for Q4 2025.

  • For Q4 2025, Capital Leases rose 3.62% year-over-year to $268.9 million; the TTM value through Dec 2025 reached $268.9 million, up 3.62%, while the annual FY2025 figure was $268.9 million, 3.62% up from the prior year.
  • Capital Leases for Q4 2025 was $268.9 million at Nutex Health, roughly flat from $270.1 million in the prior quarter.
  • Across five years, Capital Leases topped out at $270.1 million in Q3 2025 and bottomed at $65.7 million in Q4 2021.
  • The 5-year median for Capital Leases is $224.1 million (2023), against an average of $223.8 million.
  • The largest annual shift saw Capital Leases surged 209.76% in 2022 before it decreased 8.67% in 2024.
  • A 5-year view of Capital Leases shows it stood at $65.7 million in 2021, then soared by 209.76% to $203.6 million in 2022, then grew by 5.04% to $213.9 million in 2023, then rose by 21.32% to $259.5 million in 2024, then grew by 3.62% to $268.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Capital Leases are $268.9 million (Q4 2025), $270.1 million (Q3 2025), and $258.0 million (Q2 2025).